NASDAQ:SPRO
Spero Therapeutics
- Stock
Last Close
1.37
30/08 20:00
Market Cap
73.42M
Beta: 0.87
Volume Today
58.38K
Avg: 603.93K
PE Ratio
−115.83
PFCF: 2.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -13.15M - | -32.64M 148.16% | -39.89M 22.20% | -41.66M 4.45% | -60.92M 46.24% | -78.28M 28.49% | -89.76M 14.66% | -46.41M 48.29% | 22.81M 149.13% | |
depreciation and amortization | 11K - | 279K 2,436.36% | 363K 30.11% | 409K 12.67% | 750K 83.37% | 761K 1.47% | 646K 15.11% | 869K 34.52% | 367K 57.77% | |
deferred income tax | -174K - | -580K 233.33% | 83K 114.31% | -808K - | -362K 55.20% | 60K 116.57% | -8.37M - | |||
stock based compensation | 21K - | 180K 757.14% | 1.43M 692.78% | 2.75M 92.64% | 3.78M 37.36% | 4.89M 29.45% | 9.43M 92.92% | 9.12M 3.26% | 7.93M 13.05% | |
change in working capital | 170K - | -792K 565.88% | 443K 155.93% | -1.07M 341.76% | 6.83M 737.82% | -13.39M 296.05% | 12.90M 196.33% | 22.09M 71.20% | -70.38M 418.63% | |
accounts receivables | -7.08M - | 2.18M 130.71% | 3.83M 76.10% | 1.55M 59.63% | -461K 129.80% | |||||
inventory | 7.08M - | -2.18M 130.71% | -3.83M 76.10% | -1.55M 59.63% | ||||||
accounts payables | 671K - | -644K 195.98% | 2.35M 464.75% | 84K 96.42% | 564K 571.43% | -2.98M 627.48% | -53K 98.22% | -484K 813.21% | 761K 257.23% | |
other working capital | -501K - | -148K 70.46% | -1.91M 1,187.84% | -1.16M 39.40% | 6.27M 642.60% | -10.42M 266.22% | 12.95M 224.35% | 22.57M 74.24% | -70.67M 413.12% | |
other non cash items | 3.52M - | 4.59M 30.65% | -1.54M 133.54% | -50K 96.76% | 356K 812.00% | 513K 44.10% | 2.37M 362.38% | 6.61M 178.46% | 14.64M 121.67% | |
net cash provided by operating activities | -9.61M - | -28.96M 201.41% | -39.11M 35.06% | -39.63M 1.31% | -50.02M 26.23% | -85.87M 71.68% | -64.35M 25.07% | -7.73M 87.99% | -32.99M 326.79% | |
investments in property plant and equipment | -232K - | -830K 257.76% | -27K 96.75% | -2.44M 8,922.22% | -314K 87.11% | -157K 50% | 39K 124.84% | |||
acquisitions net | 83.16M - | -29.84M 135.89% | -10.63M 64.39% | -39K 99.63% | ||||||
purchases of investments | -130.18M - | -88.99M 31.64% | -45.72M 48.62% | -43.91M 3.95% | -26.97M 38.59% | |||||
sales maturities of investments | 49.45M - | 118.84M 140.29% | 56.35M 52.58% | 51.55M 8.52% | 60.78M 17.90% | |||||
other investing activites | -83.16M - | 29.84M 135.89% | 10.63M 64.39% | 39K 99.63% | ||||||
net cash used for investing activites | -232K - | -830K 257.76% | -27K 96.75% | -83.16M 307,885.19% | 29.53M 135.51% | 10.47M 64.54% | 7.67M 26.72% | 33.81M 340.65% | ||
debt repayment | -333K - | -47.48M 14,158.26% | -54.48M 14.75% | |||||||
common stock issued | 77.75M - | 70.50M 9.32% | 15.79M 77.60% | 78.66M 398.16% | 35.37M 55.04% | 24.51M 30.69% | 221K 99.10% | |||
common stock repurchased | 27.54M - | 10.28M 62.68% | ||||||||
dividends paid | -47.48M - | -54.48M 14.75% | ||||||||
other financing activites | 15.28M - | 34.41M 125.29% | 38.36M 11.48% | -977K 102.55% | 350K 135.82% | 52.55M 14,915.43% | 116.11M 120.93% | 44.63M 61.56% | ||
net cash used provided by financing activities | 15.28M - | 34.41M 125.29% | 116.11M 237.40% | 69.52M 40.12% | 16.14M 76.78% | 130.88M 710.91% | 84.05M 35.78% | -29.55M 135.16% | 221K 100.75% | |
effect of forex changes on cash | ||||||||||
net change in cash | 5.43M - | 4.62M 14.92% | 76.97M 1,564.64% | -53.26M 169.19% | -4.35M 91.83% | 55.48M 1,375.38% | 27.38M 50.66% | -3.48M 112.70% | -32.77M 842.59% | |
cash at beginning of period | 256K - | 5.69M 2,123.05% | 10.31M 81.25% | 87.34M 746.71% | 34.08M 60.98% | 29.73M 12.76% | 85.21M 186.61% | 112.58M 32.13% | 109.11M 3.09% | |
cash at end of period | 5.69M - | 10.31M 81.25% | 87.29M 746.22% | 34.08M 60.96% | 29.73M 12.76% | 85.21M 186.61% | 112.58M 32.13% | 109.11M 3.09% | 76.33M 30.04% | |
operating cash flow | -9.61M - | -28.96M 201.41% | -39.11M 35.06% | -39.63M 1.31% | -50.02M 26.23% | -85.87M 71.68% | -64.35M 25.07% | -7.73M 87.99% | -32.99M 326.79% | |
capital expenditure | -232K - | -830K 257.76% | -27K 96.75% | -2.44M 8,922.22% | -314K 87.11% | -157K 50% | 39K 124.84% | |||
free cash flow | -9.84M - | -29.79M 202.73% | -39.14M 31.38% | -42.06M 7.47% | -50.33M 19.67% | -86.03M 70.92% | -64.31M 25.25% | -7.73M 87.98% | -32.99M 326.79% |
All numbers in USD (except ratios and percentages)